HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Journal Article

HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.

Full Text

Duke Authors

Cited Authors

  • Khurana, S; Norris, PJ; Busch, MP; Haynes, BF; Park, S; Sasono, P; Mlisana, K; Salim, AK; Hecht, FM; Mulenga, J; Chomba, E; Hunter, E; Allen, S; Nemo, G; Rodriguez-Chavez, IR; Women's Interagency HIV Study Collaborative Study Group, ; Margolick, JB; Multicenter AIDS Cohort Study (MACS), ; Golding, H

Published Date

  • January 2010

Published In

Volume / Issue

  • 48 / 1

Start / End Page

  • 281 - 285

PubMed ID

  • 19906903

Pubmed Central ID

  • 19906903

Electronic International Standard Serial Number (EISSN)

  • 1098-660X

Digital Object Identifier (DOI)

  • 10.1128/JCM.01573-09

Language

  • eng

Conference Location

  • United States